Statements (55)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Person
|
| gptkbp:affiliation |
gptkb:German_Cancer_Research_Center
gptkb:University_of_Mainz |
| gptkbp:alma_mater |
gptkb:Hannover_Medical_School
|
| gptkbp:award |
gptkb:German_Federal_Cross_of_Merit
gptkb:European_Inventor_Award |
| gptkbp:birth_date |
1965-09-19
|
| gptkbp:birth_place |
Iskenderun, Turkey
|
| gptkbp:field |
oncology
immunology |
| gptkbp:founder |
gptkb:Bio_NTech
Ganymed Pharmaceuticals |
| https://www.w3.org/2000/01/rdf-schema#label |
Ugur Sahin
|
| gptkbp:influenced_by |
gptkb:Paul_Ehrlich
gptkb:Albert_Calmette |
| gptkbp:invention |
gptkb:BNT162b2
gptkb:Comirnaty cancer therapies m RNA-based vaccines |
| gptkbp:involvement |
gptkb:scientific_research
entrepreneurship COVID-19 pandemic response clinical trials public health initiatives research funding collaborative projects healthcare policy discussions scientific publications global health initiatives media appearances biotechnology industry vaccine development international health organizations academic partnerships patent filings public speaking engagements research collaborations scientific advisory boards vaccine distribution efforts biomedical ethics discussions government advisory roles pharmaceutical collaborations vaccine equity discussions |
| gptkbp:known_for |
developing COVID-19 vaccine
co-founding Bio NTech |
| gptkbp:nationality |
gptkb:German
|
| gptkbp:occupation |
gptkb:Physician
biotech entrepreneur |
| gptkbp:research_focus |
infectious diseases
cancer immunotherapy m RNA technology |
| gptkbp:residence |
gptkb:Mainz,_Germany
|
| gptkbp:spouse |
gptkb:Ozlem_Tureci
|
| gptkbp:bfsParent |
gptkb:Pfizer/_Bio_NTech
|
| gptkbp:bfsLayer |
6
|